Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis

By McLean Leon P   Cross Raymond K   Shea-Donohue Terez  

Immunotherapy, Vol. 5, Iss. 9, 2013-09 ,pp. : 923-925

Future Medicine

Access to resources Recommend Favorite

IL-6gp130STAT3 in T cells directs the development of IL-17 T h with a minimum effect on that of Treg in the steady state

By Nishihara Mika   Ogura Hideki   Ueda Naoko   Tsuruoka Mineko   Kitabayashi Chika   Tsuji Fumio   Aono Hiroyuki   Ishihara Katsuhiko   Huseby Eric   Betz Ulrich A. K.   Murakami Masaaki   Hirano Toshio  

International Immunology, Vol. 19, Iss. 6, 2007-06 ,pp. : 695-702

Oxford University Press

Access to resources Recommend Favorite

IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (T_H17) Cells in the Periphery

By Ndhlovu Lishomwa   Sinclair Elizabeth   Epling Lorrie   Tan Qi   Ho Terence   Jha Aashish   Eccles-James Ijeoma   Tincati Camilla   Levy Jay   Nixon Douglas   Hecht Frederick   Barbour Jason  

Journal of Clinical Immunology, Vol. 30, Iss. 5, 2010-09 ,pp. : 681-692

Springer Publishing Company

Access to resources Recommend Favorite

Localization of IL-17++Foxp3++ T Cells in Esophageal Cancer

By Huang Chun   Fu Zhong-Xue  

Immunological Investigations, Vol. 40, Iss. 4, 2011-01 ,pp. : 400-412

Informa Healthcare

Access to resources Recommend Favorite

TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going?

By Zattra Edoardo   Stan Roxana   Russo Irene   Lo Nigro Alessandro   Peserico Andrea   Alaibac Mauro  

Immunotherapy, Vol. 5, Iss. 8, 2013-08 ,pp. : 791-794

Future Medicine

Access to resources Recommend Favorite